+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05438537

Prospective Registry to Collect Clinical Data and Biological Samples for Upper Tract Urothelial Cancer Patients Comprehensive Assessment of Disease Effects and Treatment Outcomes

Led by Chinese University of Hong Kong · Updated on 2026-10-27

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Upper Tract Urothelial Cancer UTUC is a relatively uncommon but increasingly diagnosed condition with many management challenges and controversies. Researchers aim to create a local patient registry to better understand the physical and biological aspects of UTUC and improve knowledge about its epidemiology, natural history, and treatment outcomes in Hong Kong. This observational study collects detailed clinical information and outcomes from patients with UTUC who are treated at the hospital. Blood, urine, and tumor tissue samples are also gathered to support research into new diagnostic and therapeutic agents. The registry will track patients over time to provide comprehensive data. Participants contribute by allowing their clinical data and biological samples to be collected and analyzed. Researchers will monitor long-term survival, disease recurrence, progression, and complications over a 10-year period. The study runs until December 2030, aiming to improve understanding and management of UTUC through this extensive observational registry.

CONDITIONS

Brief Title

A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)

Research Team

J

Jeremy Yuen-Chun TEOH, FRCS(Ed)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here